Lorena Medina
Physician Assistant · Pharr, TXNPI 1629375928
Payments from drug & device makers
Across 323 payments — averaging $18.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Dexcom, Inc.$803
- AbbVie$794
- GSK$695
- Lilly USA, LLC$680
- Amgen$430
- plus $2K from 17 others
What the payments were for
- Food & beverage$6,111100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 44 | $1,105 |
| Dexcom, Inc. | 14 | $803 |
| AbbVie | 73 | $794 |
| GSK | 46 | $695 |
| Lilly USA, LLC | 39 | $680 |
| Amgen | 16 | $430 |
| Novo Nordisk | 16 | $256 |
| Bayer | 16 | $240 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 18 | $217 |
| Boehringer Ingelheim | 10 | $216 |
| Mannkind Corporation | 4 | $154 |
| Philips North America LLC | 6 | $99 |
| Kowa Pharmaceuticals America, Inc. | 5 | $83 |
| Abbott | 3 | $54 |
| Madrigal Pharmaceuticals | 2 | $51 |
| Pfizer | 2 | $50 |
| Amarin Pharma, Inc. | 3 | $47 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $27 |
| Baxter Healthcare | 1 | $26 |
| Exact Sciences | 1 | $24 |
| Johnson & Johnson | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DEXCOM G6 TRANSMITTER$470
- Repatha$119
- AFREZZA$112
- DEXCOM G7 GSS (161)$108
- DEXCOM STELO GLUCOSE BIOSENSOR$108
- AIRSUPRA$106
- FARXIGA$106
How this compares
$6,111 in reported general payments places this provider in the 90th percentile of 8,308 physician assistant providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 68 | $83,335 |
| FarxigaDapagliflozin Propanediol | 84 | $75,653 |
| MounjaroTirzepatide | 31 | $62,403 |
| KerendiaFinerenone | 42 | $52,959 |
| TrulicityDulaglutide | 27 | $40,287 |
| JardianceEmpagliflozin | 23 | $32,919 |
| LinzessLinaclotide | 30 | $30,903 |
| TrulancePlecanatide | 19 | $25,035 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 17 | $23,119 |
| Tresiba Flextouch U-200Insulin Degludec | 29 | $22,564 |
| MyrbetriqMirabegron | 24 | $21,330 |
| Xigduo XrDapaglifloz Propaned/Metformin | 19 | $21,308 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 19 | $20,581 |
| EliquisApixaban | 15 | $18,522 |
| SynjardyEmpagliflozin/Metformin Hcl | 11 | $16,189 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $680 | $102,69058 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $1,105 | $98,773101 claims |
| Novo NordiskOzempic | $256 | $83,33568 claims |
| Boehringer IngelheimJardiance, Synjardy, Synjardy Xr | $216 | $60,45453 claims |
| BayerKerendia | $240 | $52,95942 claims |
| AbbVieLinzess | $794 | $30,90330 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $217 | $25,03519 claims |
| GSKTrelegy Ellipta | $695 | $20,58119 claims |
| PfizerEliquis | $50 | $18,52215 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,308 physician assistant providers in Texas.
Other physician assistant in Pharr
- Cynthia TrickettDallas$1.3M
- Kristine KuceraMelissa$797K
- Selina SantosAustin$543K
- Matthew BrunoMcKinney$538K
- Anthony DerenciusSan Antonio$507K
- Brooke HodnickSouthlake$479K
- Holly GloverArlington$418K
- Kirk GautierAthens$416K
- Jaime RomanPlano$338K
- Michael WhiteDallas$276K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.